Search results
Results from the WOW.Com Content Network
The SEER database tracks 5-year relative survival rates for non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC) in the United States, based on how far the cancer has spread. The SEER database, however, does not group cancers by AJCC TNM stages (stage 1, stage 2, stage 3, etc.).
For people with non-small cell lung cancer, prognosis depends on the stage of cancer and the subtype of NSCLC. For example, the five-year survival rate for early-stage NSCLC is 63%. This means that 63% of people diagnosed with the condition are still alive five years later.
According to the American Cancer Society, about 80–85% of all lung carcinomas fall into the non-small cell category. NSCLC doesn’t tend to spread as fast as SCLC and has a better survival...
Relative survival rates for non-small-cell lung cancer (NSCLC): Almost 90% of lung cancers are this type. The National Cancer Institute’s database breaks down the cancers by how far the...
Lung cancer is the leading cause of cancer-related deaths in men and women in the US and worldwide. 1,2 Non–small cell lung cancer (NSCLC) represents approximately 84% of all lung cancers, whereas small-cell lung cancer (SCLC) represents approximately 13%. 1 Historically, NSCLC has had a poor prognosis, particularly in later stages. 3 However ...
The life expectancy of someone with non-small cell lung cancer (NSCLC) depends on the stage of cancer and treatment. Learn about survival rates here.
Survival rates for non-small cell lung cancer (NSCLC) depend on the stage of the cancer. Learn more about the outlook for NSCLC here.
Non-small cell lung cancer (NSCLC) accounts for 80–85% of lung cancer diagnoses and typically spreads more slowly. Small cell lung cancer (SCLC) is diagnosed in 10–15% of people with lung...
Prognosis Details. Survival Rates. Factors That Influence Prognosis. Coping Strategies. FatCamer / Getty Images. Non-small cell lung cancer (NSCLC) is the most common form of lung cancer,...
According to the American Cancer Society, the 5-year survival rates for NSCLC are: Localized: 65% Regional: 37% Distant: 9% Other factors can also affect your individual outlook. These can...